Assessment of Tartrate-Resistant Acid Phosphatase (TRAP) as a Bone Resorption Marker in Stage IV Breast Cancer Patients With Bone Metastasis
CompletedOBSERVATIONAL
Enrollment
30
Participants
Timeline
Start Date
September 30, 2004
Primary Completion Date
May 31, 2006
Conditions
Breast Cancer
Interventions
DRUG
Zometa(drug)
Trial Locations (1)
40202
James Graham Brown Cancer Center, 529 S. Jackson St., Louisville
All Listed Sponsors
collaborator
James Graham Brown Cancer Center
OTHER
lead
University of Louisville
OTHER
NCT00264082 - Assessment of Tartrate-Resistant Acid Phosphatase (TRAP) as a Bone Resorption Marker in Stage IV Breast Cancer Patients With Bone Metastasis | Biotech Hunter | Biotech Hunter